Ceftobiprole medocaril

Trade Name: 
Zeftera
Manufacturer/Distributor: 
Janssen-Ortho
Classification: 
Cephalosporin antibiotic
ATC Class: 
J01DI01 Ceftobiprole medocaril
Status: 
discontinued
Date Marketed in Canada (yyyy/mm/dd): 
2010/04/16
Presentation: 
Vial for injection: 500 mg; DIN: 02313103
Comments: 
Discontinued in Canada following regulatory recommendations in the United States and the European Union to not approve Zeftera ( due to concerns regarding the conduct of clinical trials). Further information can be obtained from the Health Canada Advisories, Warning and Recalls website (http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2010/index-eng.php).